LFG
VRTX icon

Larson Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Larson Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Sell
1,302
-17
-1% -$7.53K 0.02% 485
2026
Q1 		$589K Buy
1,319
+232
+21% +$108K 0.02% 432
2025
Q4 		$493K Buy
1,087
+224
+26% +$96.5K 0.02% 467
2025
Q3 		$338K Buy
863
+52
+6% +$21.7K 0.01% 579
2025
Q2 		$361K Sell
811
-25
-3% -$11.5K 0.01% 523
2025
Q1 		$405K Buy
836
+350
+72% +$163K 0.02% 451
2024
Q4 		$196K Buy
486
+69
+17% +$32K 0.01% 568
2024
Q3 		$194K Buy
417
+75
+22% +$36K 0.01% 585
2024
Q2 		$160K Buy
342
+114
+50% +$49.5K 0.01% 531
2024
Q1 		$95.3K Buy
228
+200
+714% +$84.5K 0.01% 553
2023
Q4 		$11.4K Sell
28
-78
-74% -$28.8K ﹤0.01% 980
2023
Q3 		$36.9K Buy
106
+51
+93% +$17.8K ﹤0.01% 689
2023
Q2 		$19.4K Buy
55
+30
+120% +$10.1K ﹤0.01% 744
2023
Q1 		$7.88K Hold
25
– – ﹤0.01% 989
2022
Q4 		$7.22K Hold
25
– – ﹤0.01% 953
2022
Q3 		$7K Hold
25
– – ﹤0.01% 894
2022
Q2 		$7K Hold
25
– – ﹤0.01% 808
2022
Q1 		$7K Hold
25
– – ﹤0.01% 746
2021
Q4 		$5K Buy
+25
New +$4.86K ﹤0.01% 828
2019
Q3 		– Sell
-25
Closed -$5K – 629
2019
Q2 		$5K Buy
+25
New +$4.37K ﹤0.01% 322

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Larson Financial Group's VRTX Position: Q2 2026 in Review

Larson Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q2 2026, selling an estimated $7.53K and leaving 1,302 shares worth $647K. The position accounts for 0.02% of the portfolio, ranked #485.

Larson Financial Group first reported a position in VRTX in Q2 2019 and has held it in 20 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Larson Financial Group held 1,302 shares of Vertex Pharmaceuticals worth $647K as of Q2 2026.
  • Larson Financial Group sold 17 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.53K.
  • Vertex Pharmaceuticals made up 0.02% of Larson Financial Group's portfolio in Q2 2026, its #485 holding.
  • Larson Financial Group first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 20 quarters since.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.